These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 5577943)
1. [Action of lysine on the hyperammoniema of the cirrhotic patient]. Lemonnier F; Goutand G; Caroli J Presse Med (1893); 1971 May; 7(23):1063-6. PubMed ID: 5577943 [No Abstract] [Full Text] [Related]
2. [Changes in plasma glucagon, insulin, C-peptide and amino acids during the intravenous induced hyperammonemia test in the cirrhotic]. Doffoël M; Zarski JP; Schlienger JL; Raul F; Marescarux J; Imler M; Bockel R Gastroenterol Clin Biol; 1981 Dec; 5(12):1087-94. PubMed ID: 7033034 [No Abstract] [Full Text] [Related]
3. Effect of pyridoxine alpha-ketoglutarate (PAK) on ammonia and pyruvic and lactic acid blood levels in patients with cirrhosis. Salerno F; Abbiati R; Fici F Int J Clin Pharmacol Res; 1983; 3(1):21-5. PubMed ID: 6679504 [TBL] [Abstract][Full Text] [Related]
4. [Action of ornighine alpha-ketoglutarate on hyperammoniemia in the cirrhotic patient]. Michel H; Ogé P; Bertrand L Presse Med (1893); 1971 Apr; 79(19):867-8. PubMed ID: 5576498 [No Abstract] [Full Text] [Related]
5. [On the effect of neomycin on blood ammonia, free amino acids and free phenols in serum and urine in liver cirrhosis]. Müting D; Reikowski J; Reikowski H Med Welt; 1968 May; 19():1235-9. PubMed ID: 5728824 [No Abstract] [Full Text] [Related]
6. [Plasma amino acids in patients with liver cirrhosis treated with lactulose]. Giardina MG; Matarazzo M; Prantera T; Verre C; De Marco F Boll Soc Ital Biol Sper; 1984 Dec; 60(12):2309-16. PubMed ID: 6529509 [TBL] [Abstract][Full Text] [Related]
7. [Modification of indices of hepatic and thyroid function in cirrhotic patients during therapy with amino acid solutions with high content of branched-chain amino acids]. Roffi L; Paleari F; Colombo MC; Mandelli AG; Chinea B; Gastaldi F Clin Ter; 1982 Sep; 102(5):443-63. PubMed ID: 7151369 [No Abstract] [Full Text] [Related]
8. [Proceedings: Experimental study on changes of ammoniemia and aminoacidemia levels following oral doses of L-glutamic acid for differentiation of liver cirrhosis (preliminary note)]. Fumero S; Benzio G; Carnevale S; Bertasso L Quad Sclavo Diagn; 1973 Mar; 9(1):307-20. PubMed ID: 4788718 [No Abstract] [Full Text] [Related]
9. Early and late changes in fasting and absorptive plasma amino acids and ammonia after distal splenorenal shunt in cirrhosis. Trevisani F; Bernardi M; Arienti V; Scrivano P; Mazziotti A; Cavallari A; Patrono D; Piazzi S; Gozzetti G; Gasbarrini G Hepatology; 1994 Feb; 19(2):329-38. PubMed ID: 8294090 [TBL] [Abstract][Full Text] [Related]
10. Comparison of the effect of various amino acids upon the blood ammonia concentration of patients with liver disease. Rudman D; Galambos JT; Smith RB; Salam AA; Warren WD Am J Clin Nutr; 1973 Sep; 26(9):916-25. PubMed ID: 4727750 [No Abstract] [Full Text] [Related]
11. [Action of L-lysine during the induced hyperammoniemia test in man]. Lemonnier F; Hadchouel P; Charpentier C; Caroli J Ann Biol Clin (Paris); 1974; 32(1):41-6. PubMed ID: 4836395 [No Abstract] [Full Text] [Related]
12. [Action of ascorbic acid on ammoniemia, alpha-ketoglutaric acid, glutamic acid and glutamine in cirrhotic and normal subjects]. Schirardin H; Bauer M; Warter J C R Seances Soc Biol Fil; 1967; 161(10):2060-4. PubMed ID: 4234199 [No Abstract] [Full Text] [Related]
14. Effect of sodium benzoate on blood ammonia response to oral glutamine challenge in cirrhotic patients: a note of caution. Efrati C; Masini A; Merli M; Valeriano V; Riggio O Am J Gastroenterol; 2000 Dec; 95(12):3574-8. PubMed ID: 11151894 [TBL] [Abstract][Full Text] [Related]
15. [A NEW TREATMENT OF EXCESS BLOOD AMMONIA IN CIRRHOTIC PATIENTS: LYSINE OROTATE]. CAROLI J; LEMONNIER F; HAGEGE A; MASSON S Rev Med Chir Mal Foie; 1964 Sep; 39():195-216. PubMed ID: 14203667 [No Abstract] [Full Text] [Related]
16. Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study. Kircheis G; Nilius R; Held C; Berndt H; Buchner M; Görtelmeyer R; Hendricks R; Krüger B; Kuklinski B; Meister H; Otto HJ; Rink C; Rösch W; Stauch S Hepatology; 1997 Jun; 25(6):1351-60. PubMed ID: 9185752 [TBL] [Abstract][Full Text] [Related]
17. Effect of acute lactulose administration on serum acetate levels in cirrhosis. Fernandes J; Morali G; Wolever TM; Blendis LM; Koo M; Jenkins DJ; Rao AV Clin Invest Med; 1994 Jun; 17(3):218-25. PubMed ID: 7923999 [TBL] [Abstract][Full Text] [Related]
18. [Results of personal experience with a sulfamide preparation associated with lysine orotate and pyridoxine hydrochloride, in the treatment of rheumatism of degenerative origin]. Salvatella Viñals J; Ferré LA; Barceló P Rev Esp Reum Enferm Osteoartic; 1970 Jan; 13(5):317-21. PubMed ID: 5488643 [No Abstract] [Full Text] [Related]
19. Role of meal carbohydrate content for the imbalance of plasma amino acids in patients with liver cirrhosis. Schulte-Frohlinde E; Wagenpfeil S; Willis J; Lersch C; Eckel F; Schmid R; Schusdziarra V J Gastroenterol Hepatol; 2007 Aug; 22(8):1241-8. PubMed ID: 17688664 [TBL] [Abstract][Full Text] [Related]
20. Helicobacter pylori urease inhibition and ammonia levels in cirrhotic patients. Zullo A; Rinaldi V; Folino S; Diana F; Attili AF Am J Gastroenterol; 1998 May; 93(5):851-2. PubMed ID: 9625155 [No Abstract] [Full Text] [Related] [Next] [New Search]